Organon & Co | OGN - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q3 Sep/2025 0.90 1.01 Oct/29
FY2026Q2 Jun/2026 0.89 1.00 Aug/11
FY2026Q1 Mar/2026 0.71 0.83 1.02 Apr/30
FY2025Q4 Dec/2025 0.63 0.76 0.90 Feb/12
FY2025Q3 Sep/2025 1.01 0.94 0.87 Nov/10




Eps تغيير تاريخ
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Celltrion KRW 1.35K 224.25 2026-06
Cspc Pharmaceutical CNY 0.08 0.08 2026-03
Deva Holding AS TRY 2.92 1.6 2023-09
Dianthus Therapeutics USD -0.85 0.58 2026-03
Divis Laboratories Ltd INR 28.29 6.31 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Glaxosmithkline GBP 0.62 0.41 2026-03
Kangmei Pharma CNY 0 0 2026-03
Knight Therapeutics CAD 0.13 0.22 2026-03
Laboratorios Farma EUR 1.96 0.71 2023-12
Malin Corporation EUR -0.06 0.1 2023-12
Medical Developments International AUD 0 0 2025-12
Merck USD -1.28 3.32 2026-03
Neuren Pharmaceuticals AUD 0.12 0.06 2025-12
Novartis USD 1.99 0.45 2026-03
Organigram Holdings CAD -0.01 0.15 2026-03
Organon & Co USD 0.71 0.08 2026-03
Ovoca Bio EUR -0.06 0.01 2025-06
Pharma Mar EUR 0.09 3.25 2026-03
Qiagen NV USD 0.46 0.06 2026-03
Sartorius EUR 1.2 0.06 2026-03
Sino Biopharmaceutical CNY -0.06 0.22 2025-12
Tilray USD -0.41 0.4 2025-12
Zealand Pharma A/S -8.34 2.6 2025-12